Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial - Concepedia

Concepedia

Publication | Closed Access

Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial

75

Citations

17

References

2019

Year

Rahim M. Naimi, Mark Hvistendahl, Lotte Hahn Enevoldsen, Jan Lysgaard Madsen, Stefan Fuglsang, Steen Seier Poulsen, Hannelouise Kissow, Jens Pedersen, Nikolaj Nerup, Rikard Ambrus,

The Lancet. Gastroenterology & hepatology

Functional Gastrointestinal DisorderShort Bowel SyndromeMedicineRandomised Phase 2GastroenterologyPathologyUlcerative ColitisPharmacologyDrug DiscoveryGastrointestinal Peptide Hormone

References

	Year	Citations

Page 1

Page 1